|Bid||230.00 x 1100|
|Ask||230.60 x 1800|
|Day's range||223.00 - 231.87|
|52-week range||76.59 - 331.68|
|Beta (5Y monthly)||1.62|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2021 - 12 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||264.20|
23andMe Co-Founder & CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to discuss the future of personal genomics.
Yahoo Finance's Alexis Keenan provides the latest on how businesses are handling the COVID-19 vaccine mandate.
Chinese real estate giant China Evergrande Group has warned it might default on debt. First on my list is Novavax (NASDAQ: NVAX). The company might be the next to enter the coronavirus vaccine market.